My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

4.500 -0.110 (-2.39%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >

Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? ↗

February 29, 2024

Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 29, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 29, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

Via InvestorPlace

Top 4 Health Care Stocks You May Want To Dump In February ↗

February 15, 2024

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

A Preview Of Ironwood Pharmaceuticals's Earnings ↗

February 14, 2024

Via Benzinga

Chart Of The Day: Ironwood Pharma - Gastrointestinal Products ↗

February 13, 2024

Via Talk Markets

Earnings Preview For Ironwood Pharmaceuticals ↗

August 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 19, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Via Benzinga

Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday ↗

September 19, 2023

U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround ↗

June 12, 2023

Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.

Via The Motley Fool

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

Why Ironwood Pharmaceuticals Stock Bumped Higher Today ↗

May 22, 2023

Investors indicated approval of the company's upcoming $1 billion asset purchase.

Via The Motley Fool

Recap: Ironwood Pharmaceuticals Q1 Earnings ↗

May 04, 2023

Via Benzinga

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

Earnings Outlook For Ironwood Pharmaceuticals ↗

February 15, 2023

Via Benzinga

Ironwood Scoops Up Gastrointestinal Diseases Player For $1B ↗

May 22, 2023

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has agreed to acquire VectivBio Holding AG (NASDAQ: VECT) for $17.00 per share in an all-cash transaction with an estimated aggregate consideration of...

Via Benzinga

Why Shares of VectivBio Holding Are Up Today ↗

May 22, 2023

A buyout offer by Ironwood Pharmaceuticals lifted the clinical-stage biotech's stock.

Via The Motley Fool

Merger Monday ↗

May 22, 2023

This morning, Chevron announced a deal to acquire PDC Energy for $72 per share in stock.

Via Talk Markets

Why VectivBio Shares Are Surging Monday ↗

May 22, 2023

VectivBio Holding AG (NASDAQ: VECT) shares are trading higher Monday after GI-focused healthcare company Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) agreed to

Via Benzinga

VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion ↗

May 22, 2023

Both companies are working on treatments for gastrointestinal diseases.

Via Investor's Business Daily

Benzinga Pro's Top 5 Stocks To Watch For Monday, May 22, 2023: MU, RKT, DLTR, LDOS, IRWD ↗

May 22, 2023

Micron Technology (MU) - Shares were down about 4% Monday morning following a report the Chinese government found cybersecurity issues related to Micron's products. Chinese officials have asked

Via Benzinga

3 No-Brainer Stocks to Buy Right Now for Less Than $25 ↗

February 04, 2023

All three healthcare stocks are showing solid long-term potential.

Via The Motley Fool

Why Ironwood Pharmaceuticals Shares Are Falling During Monday's Session ↗

January 09, 2023

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below analyst estimates and issued FY23 sales...

Via Benzinga

Ironwood Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2022

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Ironwood Shares Positive Top-line Data From Late-Stage Functional Constipation Candidate Study In Patients Aged 6-17 Years ↗

September 06, 2022

Ironwood Pharmaceuticals (NASDAQ: IRWD) announced positive top-line data from its Phase 3 clinical trial evaluating LINZESS (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional...

Via Benzinga

Ironwood's Constipation Drug Shows Efficacy In Pediatric Patients ↗

September 06, 2022

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) announced topline data from a Phase 3 trial evaluating Linzess (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation.

Via Benzinga

Wells Fargo Maintains Equal-Weight Rating for Ironwood Pharmaceuticals: Here's What You Need To Know ↗

August 16, 2022

Wells Fargo has decided to maintain its Equal-Weight rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) and raise its price target from $12.00 to $13.00. Shares of Ironwood Pharmaceuticals are trading...

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

July 18, 2022

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.